Alumis ALMS
NASDAQ ALMS
$23.96 +0.93 (+4.04%)
At close: Aug 25, 2026 · 4:00 PM EDT

Alumis (ALMS) Return on Assets (2024 - 2026)

Alumis (ALMS) posted quarterly Return on Assets of 0.01% for Q4 2025, little changed year-over-year from 0.01% in Q4 2024, and down 60.42% quarter-over-quarter from 0.0% in Q3 2025.

Alumis (ALMS) Return on Assets (2024 - 2026) Analysis & Trends

Alumis (ALMS) has reported Return on Assets for 2 consecutive years, with 0.01% the latest figure, recorded in Q4 2025.

  • In Q4 2025, Return on Assets changed 0.0% year-over-year to 0.01%; the TTM figure through Dec 2025 stood at 0.01% (changed 0.0% YoY), while the FY2025 annual figure was 0.01%, changed 0.0% from the prior year.
  • Return on Assets fell to 0.01% in Q4 2025 per ALMS's latest filing, from 0.0% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.0% in Q3 2025 and bottomed at 0.01% in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Vertex Pharmaceuticals 140.32 Bn 132.47 Bn 2.84 Bn 0.00%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 0.00%
3 Argenx Se 63.35 Bn 58.16 Bn 1.37 Bn -
4 Moderna 63.15 Bn 58.01 Bn 52.00 Mn 0.00%
5 BeOne Medicines 41.96 Bn 36.86 Bn 1.53 Bn 0.00%
6 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn 0.00%
7 Royalty Pharma 27.67 Bn 26.83 Bn - 0.00%
8 BioNTech SE 27.52 Bn 9.13 Bn 668.28 Mn 0.00%
9 Insmed 26.98 Bn 25.82 Bn 358.27 Mn 0.00%
10 Alumis 3.06 Bn 2.56 Bn - 0.00%

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00%
Dec 31, 2025 -0.01%
Sep 30, 2025 0.00%
Jun 30, 2025 0.00%
Mar 31, 2025 -0.01%
Dec 31, 2024 -0.01%
Sep 30, 2024 -0.01%